(Q50658598)

17 March 2018

title

Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk. (English)

1 reference

17 March 2018

1 reference

I Mateo

1

1 reference

17 March 2018

J Llorca

2

1 reference

17 March 2018

J Infante

3

1 reference

17 March 2018

E Rodríguez-Rodríguez

4

1 reference

17 March 2018

J Berciano

5

1 reference

17 March 2018

O Combarros

6

1 reference

17 March 2018

publication date

1 March 2008

1 reference

17 March 2018

European Journal of Neurology

published in

1 reference

17 March 2018

volume

15

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

219-222

1 reference

17 March 2018

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

14-3-3zeta is an effector of tau protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

An association study between polymorphisms in three genes of 14-3-3 (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein) family and paranoid schizophrenia in northern Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Peripheral sensory neuropathy and cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

Consistency in gene-Alzheimer's disease association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2008.02059.X

10.1111/J.1468-1331.2008.02059.X

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018